50. Centers for Disease Control and Prevention. Chlamydia trachomatis genital infections—United States, 1995. MMWR Morb Mortal Wkly Rep 1997;46:193-8.
51. Addiss DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1993, 20:28-35.
52. Katz BP, Blythe MJ, Van der Pol B, Jones RB. Declining prevalence of chlamydial infection among adolescent girls. Sex Transm Dis 1996, 23:226-9.
53. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ. Trends in the prevalence of chlamydial infections. The impact of community-wide testing. Sex Transm Dis 1997, 24:169-75.
54. Herrmann B, Egger M. Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: declining rates for how much longer? Sex Transm Dis 1995, 22:253-60.
55. Dicker LW, Mosure DJ, Levine WC, Black CM, Berman SM. Impact of switching laboratory tests on reported trends in Chlamydia trachomatis infections. Am J Epidemiol 2000, 151:430-5.
56. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd ed. Washington, DC: Office of Disease Prevention and Health Promotion, U.S. Government Printing Office, 1996.
57. Munk C, Morre SA, Kjaer SK, et al. PCR-detected Chlamydia trachomatis infections from the uterine cervix of young women from the general population: prevalence and risk determinants. Sex Transm Dis 1999, 26:325-8.
58. Han Y, Coles FB, Hipp S. Screening criteria for Chlamydia trachomatis in family planning clinics: accounting for prevalence and clients' characteristics. Fam Plann Perspect 1997, 29:163-6.
59. Marrazzo JM, Fine D, Celum CL, DeLisle S, Handsfield HH. Selective screening for chlamydial infection in women: a comparison of three sets of criteria. Fam Plann Perspect 1997, 29:158-62.
60. Miller WC, Hoffman IF, Owen-O'Dowd J, et al. Selective screening for chlamydial infection: which criteria to use? Am J Prev Med 2000, 18:115-22.
61. Shaw E, Roberts D, Connor PD. Prevalence of and risk factors for Chlamydia in a rural pregnant population. J Fam Pract 1995, 41:257-60.
62. Chokephaibulkit K, Patamasucon P, List M, Moore B, Rodriguez H. Genital Chlamydia trachomatis infection in pregnant adolescents in east Tennessee: a 7-year case-control study. J Pediatr Adolesc Gynecol 1997, 10:95-100.
63. Marrazzo JM, White CL, Krekeler B, et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 1997, 127:796-803.
64. Urban MA, Coury-Doniger P, Reichman RC. Results of a screening program for Chlamydia trachomatis infection in men attending a sexually transmitted diseases clinic. Sex Transm Dis 1997, 24:587-92.
65. British Cooperative Clinical Group. Provision for sexual health care of adolescents in genitourinary medicine clinics in the United Kingdom. Genitourin Med 1997;73:453-6.
66. Ku L, Aral SO, Williams S, et al. Prevalence of Chlamydia trachomatis infection among young men in the United States: a representative national survey (abstract). 13th meeting of the International Society for Sexually Transmitted Diseases Research; July 1999.
67. Barrow RY, Mertz K, Mosure DJ, et al. Risk-based criteria for screening asymptomatic men for Chlamydia trachomatis infection: findings from a sexually transmitted disease clinic with universal testing (abstract). 47th Annual Epidemic Intelligence Service (EIS) Conference; April 1998.
68. Gaydos CA, Howell MR, Quinn TC, Gaydos JC, McKee KT. Jr Use of ligase chain reaction with urine versus cervical culture for detection of Chlamydia trachomatis in an asymptomatic military population of pregnant and nonpregnant females attending Papanicolaou smear clinics. J Clin Microbiol 1998, 36:1300-4.
69. Van Der Pol B, Quinn TC, Gaydos CA, et al. Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol 2000, 38:1105-12.
70. Chout R, Vaton S, Quist D, Bucher R, Leguyader-Desprees P, Sayada C. Improvement of cervical Chlamydia detection in asymptomatic family planning attendees by using Amplicor Chlamydia trachomatis assay. Cell Molecul Biol 1995, 41:731-6.
71. Lisby G, Scheibel J, Abrahamsson L, Christensen E, Paloheimo S. Detection of Chlamydia trachomatis in individual and pooled endocervical and urethral scrapes by a commercially available polymerase chain reaction. APMIS 1994, 102:797-800.
72. Skulnick M, Chua R, Simor A, et al. Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women. Diag Microbiol Infect Dis 1994, 20:195-201.
73. Davis JD, Riley PK, Peters CW, Rand KH. A comparison of ligase chain reaction to polymerase chain reaction in the detection of Chlamydia trachomatis endocervical infections. Infect Dis Obstet Gynecol 1998, 6:57-60.
74. van Doornum GJ, Buimer M, Prins M, Henquet CJ, Coutinho RA, Plier PK. Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction. J Clin Microbiol 1995, 33:2042-7.
75. Ossewaarde JM, van Doornum GJ, Buimer M, Choueiri B, Stary A. Differences in the sensitivity of the Amplicor Chlamydia trachomatis PCR assay. Genitourin Med 1997, 73:207-11.
76. Crotchfelt KA, Welsh LE, DeBonville D, Rosenstraus M, Quinn TC. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol 1997, 35:1536-40.
77. Hallsworth PG, Hefford C, Waddell RG, Gordon DL. Comparison of antigen detection, polymerase chain reaction and culture for detection of Chlamydia trachomatis in genital infection. Pathology 1995, 27:168-71.
78. Quinn TC, Welsh L, Lentz A, et al. Diagnosis by AMPLICOR PCR of Chlamydia trachomatis infection in urine samples from women and men attending sexually transmitted disease clinics. J Clin Microbiol 1996, 34:1401-6.
79. Toye B, Peeling RW, Jessamine P, Claman P, Gemmill I. Diagnosis of Chlamydia trachomatis infections in asymptomatic men and women by PCR assay. J Clin Microbiol 1996, 34:1396-1400.
80. Mahony JB, Luinstra KE, Sellors JW, et al. Role of confirmatory PCRs in determining performance of chlamydia Amplicor PCR with endocervical specimens from women with a low prevalence of infection. J Clin Microbiol 1994:2490-3.
81. Haasse AM, Bagshaw S, George PM. Improved detection of Chlamydia trachomatis in endocervical samples by using a new polymerase chain reaction assay. N Z Med J 1995, 108:292-4.
82. Schachter J, Stamm WE, Quinn TC, Andrews WW, Burczak JD, Lee HH. Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol 1994, 32:2540-3.
83. Catry MA, Borrego MJ, Cardoso J, Azevedo J, Santo I. Comparison of the Amplicor Chlamydia trachomatis test and cell culture for the detection of urogenital chlamydial infections. Genitourin Med 1995, 71:247-50.
84. Carroll KC, Aldeen WE, Morrison M, Anderson R, Lee D, Mottice S. Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol 1998, 36:1630-3.
85. Bygdeman SM, Johansson M, Jonasson J, Lidbrink P, Nilsson U, Teichert C. Magic Lite Chlamydia immunoassay in urogenital samples and urine versus chlamydial culture. Int J STD AIDS 1994, 5:207-11.
86. Pasternack R, Vuorinen P, Pitkajarvi T, Koskela M, Miettinen A. Comparison of manual Amplicor PCR, Cobas Amplicor PCR, and LCx Assays for detection of Chlamydia trachomatis infection in women by using urine specimens. J Clin Microbiol 1997, 35:402-5.
87. Lee HH, Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995, 345:213-16.
88. Schachter J, Moncada J, Whidden R, Shaw H, Bolan G, Burczak JD. Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women. J Infect Dis 1995, 172:1411-4.
89. Ridgway GL, Mumtaz G, Robinson AJ, Fanchini M, Carder C, Burczak J. Comparison of the ligase chain reaction with cell culture for the diagnosis of Chlamydia trachomatis infection in women. J Clin Pathol 1996, 49:116-9.
90. Pasternack R, Vuorinen P, Kuukankorpi A, Pitkajarvi T, Miettinen A. Detection of Chlamydia trachomatis infections in women by Amplicor PCR: comparison of diagnostic performance with urine and cervical specimens. J Clin Microbiol 1996, 34:995-8.
91. Gaydos CA, Ngeow YF, Lee HH, Canavaggio M, Welsh LE, Johanson J. Urine as a diagnostic specimen for the detection of Chlamydia trachomatis in Malaysia by ligase chain reaction. Sex Transm Dis 1996:402-6.
92. Buimer M, van Doornum GJ, Ching S, Peerbooms PG, Plier PK, Ram D. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening. J Clin Microbiol 1996, 34:2395-400.
93. Chernesky MA, Jang D, Lee H, Burczak JD, Hu H, Sellors J. Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol 1994, 32:2682-5.
94. Stary A, Choueiri B, Horting-Muller I, Halisch P, Teodorowicz L. Detection of Chlamydia trachomatis in urethral and urine samples from symptomatic and asymptomatic male patients by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1996, 15:465-71.
95. Grun L, Tassano-Smith J, Carder C, Johnson AM, Robinson A, Murray E. Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ 1997, 315:226-30.
96. Bassini M, Hu HY, Domeika MA, Burczak J, Svensson LO, Lee HH. Detection of Chlamydia trachomatis in urine specimens from women by ligase chain reaction. J Clin Microbiol 1995, 33:898-900.
97. Olafsson JH, Davidsson S, Karlsso SM, Palsdottir R, Steingrimsson O. Diagnosis of Chlamydia trachomatis infection in high-risk females with PCR on first void urine. Acta Derm Vener 1996, 76:226-7.
98. Paukku M, Puolakkainen M, Apter D, Hirvonen S, Paavonen J. First-void urine testing for Chlamydia trachomatis by polymerase chain reaction in asymptomatic women. Sex Transm Dis 1997:343-6.
99. Mouton JW, Verkooyen R, van der Meijden WI, van Rijsoort-Vos TH, Goessens WH, Kluytmans JA. Detection of Chlamydia trachomatis in male and female urine specimens by using the amplified Chlamydia trachomatis test. J Clin Microbiol 1997, 35:1369-72.
100. Crotchfelt KA, Pare B, Gaydos C, Quinn TC. Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol 1998, 36:391-4.
101. Pasternack R, Vuorinen P, Miettinen A. Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J Clin Microbiol 1997, 35:676-8.
102. Oh MK, Richey CM, Pate MS, Brown PR, Hook EW III. High prevalence of Chlamydia trachomatis infections in adolescent females not having pelvic examinations: utility of PCR-based urine screening in urban adolescent clinic setting. J Adolesc Health 1997, 21:80-6.
103, Rews WW, Lee HH, Roden WJ, Mott CW. Detection of genitourinary tract Chlamydia trachomatis infection in pregnant women by ligase chain reaction assay. Obstet Gynecol 1997, 89:556-60.
104. Thejls H, Gnarpe J, Gnarpe H, et al. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology. Genitourin Med 1994, 70:300-3.
105. Witkin SS, Inglis SR, Polaneczky M. Detection of Chlamydia trachomatis and Trichomonas vaginalis by polymerase chain reaction in introital specimens from pregnant women. Am J Obstet Gynecol 1996, 175:165-7.
106. Higgins SP, Klapper PE, Struthers JK, Bailey AS, Gough AP, Moore R. Detection of male genital infection with Chlamydia trachomatis and Neisseria gonorrhoeae using an automated multiplex PCR system (Cobas Amplicor) Int J STD AIDS 1998, 9:21-4.
107. Domeika M, Bassiri M, Mardh PA. Diagnosis of genital Chlamydia trachomatis infections in asymptomatic males by testing urine by PCR. J Clin Microbiol 1994, 32:2350-2.
108. Noren L, von Krogh G, Bondesson L, Nohlgard C, Grillner L. Potential public health benefits from testing with Chlamydia trachomatis PCR technique on first void urine in men. Acta Derm Venereol 1998, 78:63-6.
109. Wiesenfeld HC, Uhrin M, Dixon BW, Sweet RL. Diagnosis of male Chlamydia trachomatis urethritis by polymerase chain reaction. Sex Transm Dis 1994, 21:268-71.
110. Chernesky MA, Chong S, Jang D, Luinstra K, Sellors J, Mahony JB. Ability of commercial ligase chain reaction and PCR assays to diagnose Chlamydia trachomatis infections in men by testing first-void urine. J Clin Microbiol 1997, 35:982-4.
111. Gun-Munro J, Mahony J, Lyn P, Luinstra K, Smaill F, Richardson H. Detection of Chlamydia trachomatis in genitourinary tract specimens using an automated enzyme-linked fluorescent immunoassay. Sex Transm Dis 1996, 23:115-9.
112. Adjei O, Lal V. Non-invasive detection of Chlamydia trachomatis genital infections in asymptomatic males and females by enzyme immunoassay (Chlamydiazyme) J Trop Med Hyg 1994, 97:51-4.
113. Steingrimsson O, Olafsson JH, Thorarinsson H, Ryan RW, Johnson RB, Tilton RC. Single-dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994, 21:43-6.
114. Talbot H, Romanowski B. Factors affecting urine EIA sensitivity in the detection of Chlamydia trachomatis in men. Genitourin Med 1994, 70:101-4.
115. Moncada J, Schachter J, Shafer MA, Williams E, Gourlay L, Lavin B. Detection of Chlamydia trachomatis in first catch urine samples from symptomatic and asymptomatic males. Sex Transm Dis 1994, 21:8-12.
116. Chernesky MA, Jang D, Sellors J, Coleman P, Bodner J, Hrusovsky I. Detection of Chlamydia trachomatis antigens in male urethral swabs and urine with a microparticle enzyme immunoassay. Sex Transm Dis 1995, 22:55-9.
117. Sanders JW, Hook EW. III, Welsh LE, Shepherd ME, Quinn TC. Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urine of asymptomatic men. J Clin Microbiol 1994, 32:24-7.
118. Domeika MA, Bassiri M, Mardh PA. Enzyme immunoassay and direct immunofluorescence for detection of Chlamydia trachomatis antigen in male first-void urine. Acta Derm Venereol 1994, 74:323-6.
119. Stary A, Tomazic-Allen S, Choueiri B, Burczak J, Steyrer K, Lee H. Comparison of DNA amplification methods for the detection of Chlamydia trachomatis in first-void urine from asymptomatic military recruits. Sex Transm Dis 1996, 23:97-102.
120. Chernesky MA, Lee H, Schachter J, Burczak JD, Stamm WE, McCormack WM. Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis 1994, 170:1308-11.
121. Stary A, Schuh E, Kerschbaumer M, Gotz B, Lee H. Performance of transcription-mediated amplification and ligase chain reaction assays for detection of chlamydial infection in urogenital samples obtained by invasive and noninvasive methods. J Clin Microbiol 1998, 36:2666-70.
122. Orr P, Sherman E, Blanchard J, Fast M, Hammond G, Brunham R. Epidemiology of infection due to Chlamydia trachomatis in Manitoba, Canada. Clin Infect Dis 1994, 19:876-83.
123. Oh MK, Cloud GA, Fleenor M, Sturdevant MS, Nesmith JD, Feinstein RA. Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study. J Adolesc Health 1996, 18:270-5.
124. Kent CK, Litchfield W, Whittington W, et al. Factors associated with persistent and recurrent chlamydial infection in women (abstract). International Congress of Sexually Transmitted Disease; October 1997.
125. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis 1997, 24:131-41.
126. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med 1998, 128:277-84.
127. Humphreys JT, Henneberry JF, Rickard RS, Beebe JL. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics. Sex Transm Dis 1992, 19:47-53.
128. Sellors JW, Pickard L, Gafni A, et al. Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women. Arch Intern Med 1992, 152:1837-44.
129. Howell MR, Quinn TC, Brathwaite W, Gaydos CA. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis 1998, 25:108-17.
130. Genc M, Mardh A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996, 124:1-7.
131. Gift TL, Pate MS, Hook EW III, Kassler WJ. The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis. Sex Transm Dis 1999, 26:232-40.
132. Nettleman MD, Bell TA. Cost-effectiveness of prenatal testing for Chlamydia trachomatis. Am J Obstet Gynecol 1991, 164:1289-94.
133. Golden MR, Whittington WL, Gorbach PM, Coronado N, Boyd MA, Holmes KK. Partner notification for chlamydial infections among private sector clinicians in Seattle-King County: a clinician and patient survey. Sex Transm Dis 1999, 26:543-7.
[a]Nelson: Division of Medical Informatics and Outcomes Research and Evidence-based Practice Center, Oregon Health Sciences University, Portland, OR.
[b]Nelson, Helfand: Portland Veterans Affairs Medical Center, Portland, OR.
This document is in the public domain within the United States as stated in AHRQ's license agreement with the American Journal of Preventive Medicine. For information on reprinting, contact Randie Siegel, Director, Division of Printing and Electronic Publishing, Agency for Healthcare Research and Quality, Suite 501, 2101 East Jefferson Street, Rockville, MD 20852. Requests for linking or to incorporate content in electronic resources should be sent to: info@ahrq.gov.
Source: Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med 2001;20(3S):95-107 (http://www.elsevier.com/locate/ajpmonline).
Disclaimer: The authors of this article are responsible for its contents, including any clinical or treatment recommendations. No statement in this article should be construed as an official position of the U.S. Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
The USPSTF recommendations based on this evidence review can be found in Screening for Chlamydial Infection: Recommendations and Rationale.
Internet Citation:
Screening for Chlamydial Infection: Summary of the Evidence. Article originally in Am J Prev Med 2001;20(3S):95-107. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/ajpmsuppl/nelson1.htm.
Return to USPSTF Recommendations
U.S. Preventive Services Task Force (USPSTF)
Clinical Information
AHRQ Home Page